from$108
Peptide Blends · SKU BLD-CI-5-5
CJC-1295 + Ipamorelin
No-DAC CJC-1295 with Ipamorelin for growth-hormone-axis research.
$ 90 per 5/5 mg vial · free shipping over $300
Size
In stock · ships same day on orders before 2pm ET
Purity (HPLC-UV)≥99.0% on lot BL-2608-E
IdentityConfirmed by LC-MS
FormLyophilized powder, sealed vial
Endotoxin< 0.5 EU/mg (LAL)
Storage-20°C sealed · 2-8°C reconstituted
CertificateView COA for BL-2608-E →
Molecular formulaModified GRF (1-29), no DAC + ipamorelin
Residues29 + 5
PubChemCID 9831659
Volume pricing, applied automatically in the cart
| Quantity | Per unit | You save |
|---|---|---|
| 3 to 4 units | $83.70 | 7% |
| 5 to 9 units | $80.10 | 11% |
| 10+ units | $75.60 | 16% |
Verify lot BL-2608-E in the COA library · This month's lot report
Ships same day on orders before 2pm ET. For laboratory research use only. Not for human or animal consumption.
Frequently bought together
Supplies researchers add to this order
Reconstitution solution30 mL · $25
Reconstitution kitKit · $49.99
What is CJC-1295 + Ipamorelin?
This blend combines CJC-1295 without DAC, a growth-hormone-releasing-hormone analogue, with Ipamorelin, a selective growth-hormone secretagogue, co-lyophilized at 5 mg each. The two act on different receptors in the same pathway, which is why they are paired in research on pulsatile growth-hormone release. The no-DAC form is used because it keeps the short half-life of the native hormone, so timing in pulse studies is preserved.
→Read the full CJC-1295 + Ipamorelin research guide
What is CJC-1295 + Ipamorelin studied for?
- Pulsatile growth-hormone release models
- GHRH receptor and ghrelin receptor co-activation
- IGF-1 axis signalling studies
- Comparison against Tesamorelin and single secretagogues
All applications above are in-vitro or preclinical research contexts. CJC-1295 + Ipamorelin is sold for laboratory research only and is not for human or animal use.
What does the certificate for lot BL-2608-E show?
Every lot of CJC-1295 + Ipamorelin is tested by an independent US laboratory before it is listed. The report for lot BL-2608-E is in the COA library and the lot number printed on the vial matches it. The current results:
| Test | Method | Lot BL-2608-E result |
|---|---|---|
| Identity | LC-MS | Matches the calculated mass for the sequence |
| Purity | HPLC-UV, 220 nm | 99.0% |
| Net peptide content | Amino acid analysis | Stated per vial on the certificate |
| Endotoxin | LAL, chromogenic | < 0.5 EU/mg |
| Sterility | USP <71> | Pass |
How is CJC-1295 + Ipamorelin handled and stored?
Sealed vials are stored at -20°C away from light and keep for 24 months. To reconstitute, add bacteriostatic water slowly down the inside wall of the vial and swirl until clear; never shake. Once in solution, keep at 2 to 8°C and use within the 28-day window on the certificate. The reconstitution guide covers volumes and syringe units and the concentration table gives the numbers for this vial.
Frequently asked questions
Why the no-DAC form of CJC-1295?
The DAC modification extends half-life to days, which flattens pulsatility. Without it the peptide mirrors native GHRH timing, which most pulse studies require.
What does lot BL-2608-E report?
Both peptides at 99.0% or above by HPLC-UV, identity by LC-MS for each, and endotoxin below 0.5 EU per mg.
Is Ipamorelin available on its own?
Yes, as a 5 mg single vial, and the GH axis set bundle pairs this blend with Tesamorelin.
Is CJC-1295 + Ipamorelin for human use?
No. Every product on this site is sold for in-vitro laboratory research only and is not for human or animal consumption, diagnostic or therapeutic use.
Related reading
Related
More in Peptide Blends
from$200
from$200
from$150
